Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
Nautilus Biotechnology (NASDAQ: NAUT), a pioneer in single-molecule protein analysis platforms, has announced its participation in the Inaugural Guggenheim Healthcare Conference. The company's management will engage in a fireside chat on Wednesday, November 13, 2024, at 9:30 a.m. Eastern Time. The presentation will be accessible via live and archived webcast through the 'Investors' section of www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), pioniere nelle piattaforme di analisi delle proteine a singola molecola, ha annunciato la sua partecipazione alla Prima Conferenza Sanitaria Guggenheim. La direzione dell'azienda parteciperà a una chiacchierata informale mercoledì 13 novembre 2024, alle 9:30 ora orientale. La presentazione sarà disponibile tramite webcast in diretta e registrato nella sezione 'Investitori' di www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), pionera en plataformas de análisis de proteínas de molécula única, ha anunciado su participación en la Conferencia de Salud Inaugural de Guggenheim. La dirección de la empresa participará en una charla informal el miércoles 13 de noviembre de 2024, a las 9:30 a.m., hora del este. La presentación estará disponible a través de una transmisión en vivo y grabada en la sección 'Inversores' de www.nautilus.bio.
나우틸러스 바이오기술 (NASDAQ: NAUT)는 단일 분자 단백질 분석 플랫폼의 선두주자로서 구겐하임 헬스케어 회의에 참여한다고 발표했습니다. 회사 경영진은 2024년 11월 13일 수요일 오전 9시 30분(동부 시간) 비공식 대화에 참여할 것입니다. 발표는 www.nautilus.bio의 '투자자' 섹션을 통해 실시간과 녹화된 웹캐스트로 제공될 예정입니다.
Nautilus Biotechnology (NASDAQ: NAUT), un pionnier dans les plateformes d'analyse des protéines à molécule unique, a annoncé sa participation à la Première Conférence de Santé Guggenheim. La direction de l'entreprise participera à une discussion informelle mercredi 13 novembre 2024, à 9h30, heure de l'Est. La présentation sera accessible via un webinaire en direct et enregistré dans la section 'Investisseurs' de www.nautilus.bio.
Nautilus Biotechnology (NASDAQ: NAUT), ein Pionier in der Analyseplattform für einzelne Molekülproteine, hat seine Teilnahme an der Ersten Guggenheim Gesundheitskonferenz angekündigt. Das Management des Unternehmens wird am Mittwoch, den 13. November 2024, um 9:30 Uhr Eastern Time an einem informellen Gespräch teilnehmen. Die Präsentation wird über einen Live- und aufgezeichneten Webcast im Bereich 'Investoren' von www.nautilus.bio zugänglich sein.
- None.
- None.
SEATTLE, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the Inaugural Guggenheim Healthcare Conference.
Nautilus’ management is scheduled to participate in a fireside chat on Wednesday, November 13, 2024, at 9:30 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
FAQ
When is Nautilus Biotechnology (NAUT) presenting at the Guggenheim Healthcare Conference?
How can investors watch Nautilus Biotechnology's (NAUT) Guggenheim Conference presentation?
What type of presentation will Nautilus Biotechnology (NAUT) give at the Guggenheim Healthcare Conference?
Is this the first Guggenheim Healthcare Conference where Nautilus (NAUT) is participating?
